Back | Next |
home / stock / gnpx / gnpx message board
Subject | By | Source | When |
---|---|---|---|
Why you spend so much time ragging this | maximumgriff | investorshub | 01/04/2022 1:10:36 PM |
The only cash they have is possibly from | laraz5 | investorshub | 01/04/2022 1:07:53 PM |
whytestocks: $GNPX News Article - Genprex Expands Gene Therapy Oncology Pipeline to Include Small Ce | whytestocks | investorshangout | 01/04/2022 1:05:51 PM |
Are you long or short? | J2003 | investorshub | 01/04/2022 1:03:44 PM |
Smells like offering | europtiger | investorshub | 01/04/2022 12:08:32 PM |
J L: GNPX - Easy Money Rundown https://youtu.be/piaIwseoHcA | J L | investorshangout | 01/04/2022 1:35:28 AM |
Lets open at $6-$7 tomorrow | J2003 | investorshub | 01/04/2022 12:42:19 AM |
Doesnt mean no offering | Gizzer211 | investorshub | 01/04/2022 12:33:39 AM |
Tomorrow will be fun | J2003 | investorshub | 01/04/2022 12:15:16 AM |
Lol, they have plenty of cash on hand | maximumgriff | investorshub | 01/04/2022 12:06:27 AM |
Go back and read all the PRs from | laraz5 | investorshub | 01/03/2022 11:54:50 PM |
Hoping no offering after 8pm | Gizzer211 | investorshub | 01/03/2022 11:52:12 PM |
J L: GNPX - Isn't Done Running, Home Run Play https://youtu.be/ZBOu CoaZQI | J L | investorshangout | 01/03/2022 10:48:02 PM |
I do not invest in pyramid schemes? $GNPX was | laraz5 | investorshub | 01/03/2022 9:35:15 PM |
Lol, you missed out on some huge gains. | maximumgriff | investorshub | 01/03/2022 9:28:20 PM |
How many millions diluted today? You'll never know because | laraz5 | investorshub | 01/03/2022 9:24:09 PM |
0.30 or $30? Go figure | J2003 | investorshub | 01/03/2022 8:49:14 PM |
Lets do parabolic move!!! | J2003 | investorshub | 01/03/2022 8:48:38 PM |
New highs are coming | J2003 | investorshub | 01/03/2022 8:45:50 PM |
Could see $4+ AH easy. Traded the whole | Microlytics | investorshub | 01/03/2022 8:07:34 PM |
News, Short Squeeze, Breakout and More Instantly...
Genprex Issues Stockholder Letter and Provides 2024 Corporate Update PR Newswire Company Achieves Multiple Clinical Development Milestones in 2024 Patient Treatment Continues in Three Lung Cancer Clinical Trials AUSTIN, Texas , June 27, 2024 /PRNe...
Genprex to Present at the 2024 BIO International Convention PR Newswire Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas , May 30, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: ...